Cavotec SA - Interim report January - December 2020
Resilient profitability and record cashflow despite lower revenue
OCTOBER – DECEMBER 2020
- Revenue decreased -15.7% to EUR 40.3 million (47.8). Ports & Maritime decreased -20.8% and Airports & Industry decreased -11.3%
- EBIT excluding non-recurring items decreased to EUR 1.0 million (5.6), corresponding to a margin of 2.5% (11.8%)
- Non-recurring items include investment expenditure related to future growth for EUR 1.9 million.
- Net result for the period was EUR -4.7 million (1.8)
- Earnings per share basic and diluted amounted to EUR -0.050 (0.019)
- Operating cash flow amounted to EUR 9.6 million (9.0)
- Net debt amounted to EUR 15.3 million (Q3 2020: 19.0)
- Order backlog decreased -7.2% compared to the previous quarter to EUR 85.0 million
- Revenue decreased -19.2% to EUR 158.4 million (196.0)
- EBIT excluding non-recurring items decreased to EUR 5.4 million (15.7), corresponding to a margin of 3.4% (8.0%)
- Non-recurring items include investment expenditure related to future growth for EUR 1.9 million.
- Net result for the period was EUR -4.0 million (7.5)
- Earnings per share basic and diluted amounted to EUR -0.042 (0.080)
- Operating cash flow amounted to EUR 15.7 million (13.8)
- Leverage ratio stable at 0.98x (0.98x)
Comment from the CEO
Optimism in the face of adversity
The second wave of Covid-19 in the fourth quarter and partial lock downs continued to delay decision making and projects in our markets. Despite this revenue and EBIT improved slightly versus the third quarter 2020, while the operating cash flow was considerably stronger.
The measures we implemented early on in the year to control our costs has continued to help us mitigate the most severe effects and remain profitable during the pandemic despite lower revenue levels.
Compared with the same period 2019 revenues decreased 15.7% to EUR 40.3 million (47.8) and adjusted EBIT decreased to EUR 1.0 million (5.6), corresponding to a margin of 2.5%.
The operating cash flow amounted to EUR 9.6 million (9.0), a great achievement in the midst of a global pandemic.
The order backlog decreased 7.2% compared to the previous quarter to EUR 85.0 million. The general uncertainty impacted customer decision making, with delays to orders and approval of new investments taking longer than normal.
Despite the depressed business climate at the end of the year, we continue to be optimistic about the future. We remain more committed than ever to developing solutions that contribute to improvements in efficiency and productivity while at the same time reducing environmental impact. We actually see the pandemic making key trends of efficiency, safety and sustainability, that our solutions address, more relevant than ever.
Underpinning our optimism are some of the orders we won in the quarter that reinforces our leading position in the growing market for profitable sustainability solutions for the maritime sector.
We won automated mooring and automated e-charging systems for the world’s first fleet of zero-emission, autonomous, battery powered ships in Norway.
We were further encouraged by receiving two orders in quick succession for our next generation mooring system, MoorMaster™ NxG soon after the global launch in October. This is a testament to how MoorMaster™ can revolutionise the way ships enter and leave ports, mooring in as little as 30 seconds to drastically reduce docking times. This leads to increased loading/offloading productivity in the port where, from an environmental perspective, it results in an hour less of heavy diesel emissions for every ship, every mooring sequence and a greener, cleaner world.
Our optimistic view of the future also meant that we, despite the headwinds, increased our investments in developing our technology and products.
In October we announced that we will open a new innovation center in the Netherlands at the beginning of 2021 focusing on profitable sustainability solutions for the maritime sector. This will allow us to bring together our capabilities within areas such as artificial intelligence, remote connectivity, high power, high speed electrical charging and battery technology.
Although we have seen market challenges affecting revenue in the short term, we will continue to invest in our market position to be prepared for the expected recovery and growth in our markets. We are well positioned to fully leverage on the expected increase in demand as soon as the world returns to a more normal situation.
Lugano, 26 February 2021
Chief Executive Officer
Conference call in connection with publication of the quarterly report
A conference call for shareholders, analysts and media will be held on 26 February 2021 at 10:00 CET. Participating on the conference call from Cavotec will be Mikael Norin, CEO, and Glenn Withers, CFO.
Conference call Dial-in numbers:
Analysts & Media
Johan Hähnel – Investor Relations Manager
Mobile: +46 70 605 63 34 – Email: firstname.lastname@example.org
This is information that Cavotec SA is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out above, at 07:00 CET on 26 February 2021.
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire
Subscribe to all the latest releases from GlobeNewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire
Gilead Sciences submits new drug application in Japan for filgotinib for the treatment of ulcerative colitis with an inadequate response to conventional therapies23.4.2021 06:01:00 CEST | Press release
Application is based on Phase 2b/3 SELECTION study data with patients with moderately to severely active ulcerative colitis Mechelen, Belgium;23April 2021;06.01 CET; –Galapagos NV (Euronext & Nasdaq: GLPG) today report that their collaboration partnerGilead Sciences K.K. (“Gilead”) and Eisai Co., Ltd. (“Eisai”)today announced that Gilead submitted an application to Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) for approval of filgotinib for an additional indication to treat patients with moderately to severely active ulcerative colitis (UC).Filgotinib is a new oral Janus kinase (JAK) inhibitor approved in Japan in September 2020 for the treatment of rheumatoid arthritis. This latest regulatory submission is based on data from the randomized, double-blind, placebo-controlled Phase 2b/3 SELECTION study evaluating the efficacy and safety of filgotinib for the induction and maintenance of remission in patients with moderately to severely active ulcerative colitis who have had a
Camposol Holding PLC Invitation to the Presentation of Fourth Quarter and Audited Full Year 2020 Financial Results23.4.2021 02:00:00 CEST | Press release
Camposol Holding PLC will announce the results for the full year 2020 on Thursday, April 29, 2021. In connection with the release, a telephone conference will be held at 9:30 a.m. (Lima) as described below. The presentation will be published at 8:30 a.m. (Lima) and will be available on the Company's website. In connection with the earnings release Samuel Dyer Coriat, CEO, and Andrés Colichón Sas, CFO, will host a conference call presentation and a Q&A session at 9:30 a.m. (Lima). To participate in the conference call, please use the following numbers: London, UK Local +0800 028 8438 US/Canada International +1 409 981 0728 Zurich, Switzerland, Local +044 580 1740 Oslo, Norway, Local +47 8001 6162 Colombia, National Free Phone +01 800 518 5094 Chile, National Free Phone +56 800 914 686 Peru, National Free Phone +51 0800 71470 Participants will be asked for their name and conference ID. The Camposol conference ID is: 2466977 Audio access for the meeting is available by dialing the above-m
CrossAmerica Partners LP Maintains Quarterly Distribution22.4.2021 22:30:00 CEST | Press release
•Quarterly distribution of $0.5250 per unit attributable to the first quarter of 2021 Allentown, PA, April 22, 2021 (GLOBE NEWSWIRE) -- CrossAmerica Partners LP Maintains Quarterly Distribution Quarterly distribution of $0.5250per unit attributable to the firstquarter of 2021 ALLENTOWN, PA (April 22, 2021) – CrossAmerica Partners LP (NYSE: CAPL) announced today that the Board of Directors of its general partner has approved a quarterly distribution of $0.5250 per unit attributable to the first quarter of 2021 (annualized $2.10 per unit). The distribution attributable to the first quarter is payable on May 11, 2021 to all unitholders of record on May 4, 2021. CrossAmerica will host a conference call on May 11th at 9:00 a.m. Eastern Time to discuss first quarter earnings results, which will be released after the market closes on Monday, May 10. About CrossAmerica Partners LP CrossAmerica Partners is a leading wholesale distributor of motor fuels, convenience store operator, and owner and
Interim Report January-March 202122.4.2021 18:30:00 CEST | Press release
First quarter 2021 Net profit for the first quarter amounted to MSEK 44.6 (-4.0).Earnings per share amounted to SEK 4.00 (-0.35).Net asset value amounted to MSEK 703 (SEK 63.04 per share) at March 31, 2021, compared to MSEK 679 (SEK 60.87 per share) at March 31, 2020.Net cash amounted to MSEK 180 (SEK 16.16 per share) at March 31, 2021, compared to MSEK 219 (SEK 19.65 per share) at December 31, 2020.The 2021 Annual General Meeting resolved to pay a dividend of 3.00 SEK per share for FY 2020. Comments by the CEO NAXS experienced a steady development during the first quarter of 2021 with the NAV/share increasing by 8.5%, including the dividend paid out. During the quarter, NAXS made a second co-investment alongside JAB Holding, this time in Krispy Kreme Doughnuts, the world-famous doughnut brand. As to the underlying funds, they acquired 4 new portfolio companies and signed or closed 4 exits during the quarter. In addition, a partial exit took place with the listing of Kreate on Nasdaq H
Prosafe SE: Supporting statement to the 2020 Annual Report in light of the ruling in the Westcon matter22.4.2021 18:30:00 CEST | Press release
Reference is made to Prosafe's annual accounts for 2020 published on 25 March 2021 as well as the notice for annual general meeting published on 12 April 2021. Reference is further made to announcement on 15 April 2021, in which Prosafe informed that the Gulating Court of Appeal had decided against Prosafe in the Westcon matter, thereby awarding full payment to Westcon of amounts claimed and thus reversing the ruling by the Stavanger District Court in the first instance. In light of the ruling, Prosafe has today issued a supporting statement to its 2020 annual report and accounts. The statement is attached. Prosafe is a leading owner and operator of semi-submersible accommodation vessels. The company is listed on the Oslo Stock Exchange with ticker code PRS. For more information, please refer to www.prosafe.com Stavanger, 22 April 2021 Prosafe SE For further information, please contact: Jesper K. Andresen, CEO Phone: +47 51 65 24 30 / +47 907 65 155 Stig Harry Christiansen, Deputy CEO
Delårsrapport januari – mars 202122.4.2021 18:30:00 CEST | Pressemelding
Första kvartalet 2021 Resultat efter skatt uppgick till 44,6 (-4,0) MSEK.Resultatet per aktie uppgick till 4,00 (-0,35) SEK.Substansvärdet uppgick till 703 MSEK (63,04 SEK per aktie) per den 31 mars 2021, jämfört med 679 MSEK (SEK 60,87 per aktie) per den 31 december 2020. Nettokassan uppgick till 180 MSEK (16,16 SEK per aktie) per den 31 mars 2021, jämfört med 219 MSEK (19,65 SEK per aktie) per den 31 december 2020.Årsstämman 2021 beslutade att lämna en utdelning om 3,00 SEK per aktie. VD-kommentar NAXS utvecklades positivt under första kvartalet och substanvärdet per aktie ökade med 8,5% inklusive lämnad utdelning. Under första kvartalet gjorde NAXS ytterligare en saminvestering parallellt med JAB Holding, denna gång i Krispy Kreme Doughnuts verksamt i USA. Vad gäller underliggande fonder förvärvade dessa 4 nya portföljbolag och undertecknade eller genomförde 4 exit under perioden. Vidare genomfördes en partiell exit genom börsnotering av Kreate på Nasdaq Helsingfors. NAXS lämnade un
Conagen’s Novel Solution to Making Natural Capsaicin by Fermentation Accessible22.4.2021 18:23:30 CEST | Press release
Bedford, Mass., April 22, 2021 (GLOBE NEWSWIRE) -- Scalable, sustainable capsaicin ingredients for its use in food, consumer and industrial products have now become more accessible. Conagen announced it has successfully scaled-up its fermentation process for the production of premium capsaicin and its related capsaicinoid molecules. Chili peppers are widely used as a food additive in spicy and hot cuisines, due to its hot and pungent characteristics. Consumers globally are demanding more clean, natural and exciting flavors, especially hot and spicy flavors. Yet, the challenge in meeting this demand is that capsaicin from chili peppers is difficult to use because of its hot properties, proposing challenges to manufacturers. Capsaicin extraction is limited by the availability of chili peppers, which is subject to fluctuations in price and quality. The market for capsaicin is growing because of its pungent characteristic, which is very versatile in a broad spectrum of applications, includ